Podcast appearances and mentions of Robin Feldman

(0:00) Intro(1:26) About the podcast sponsor: The American College of Governance Counsel(2:13) Start of interview(2:45) Robin's origin story(3:55) About the AI Law and Innovation Institute.(5:02) On AI governance: "AI is critical for boards, both from a risk management perspective and from a regulatory management perspective." Boards should: 1) Get regular updates on safety and regulatory issues, 2) document the attention that they're paying to it to have a record of meaningful oversight, and 3) Most importantly, boards can't just rely on feedback from the folks in charge of the AI tools. They need a red team of skeptics.(9:58) Boards and AI Ethics. Robin's Rules of Order for AI. Rule #1: Distinguish Real-time Dangers from Distant Dangers(15:21) Antitrust Concerns in AI(18:10) Geopolitical Tensions in AI Race (US v China). "Winning the AI race is essential for the US, both from an economic and from a national security perspective."(23:30) Regulatory Framework for AI "It really isn't one size fits all for AI regulation. Europe, for the most part, is a consumer nation of AI. We are a producer nation of AI, and California in particular is a producer of AI." "There must be strong partnerships in this country between those developing cutting-edge technology and the government—because while the government holds the power, Silicon Valley holds the expertise to understand what this technology truly means."(26:46) California's AI Regulation Efforts "I do believe that over time, at some point, we will need a more comprehensive system that probably overshadows what the individual states will do, or at least cabins to some extent what the individual states will do. It will be a problem to have 50 different approaches to this, or even 20 different approaches to this within the country."(29:03) AI in the Financial Industry(33:13) Future Trends in AI. "I think the key for boards and companies is to be alert and to be nimble" and "as hard as it is, brush up a bit on your math and science, if that's not your area of expertise." "My point is simply, you have to understand these things under the hood if you're going to be able to think about what to do with them."(35:43) Her new book "AI vs IP. Rewriting Creativity" (coming out July 2025).(37:12) Key Considerations for Board Members: "It's about being nimble, staying proactive and having a proven track record of it. Most importantly, you need a red team approach."(38:26) Books that have greatly influenced her life:Rashi's Commentary on the BibleTalmud(39:06) Her mentors.Professor Robert WeisbergProfessor Gerald Gunther(41:39) Quotes that she thinks of often or lives her life by: "The cover-up's always worse than the crime."(42:34) An unusual habit or an absurd thing that she loves. Robin Feldman is the Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson '54 Distinguished Professor of Law Chair, and Director of the Center for Innovation at UC Law SF. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Well, here we are—the final episode of Informatics in the Round (we think!). After five incredible years, 38 episodes, and thousands of listeners, we've decided it's time to wrap up this journey. But first, we're taking a minute (or maybe two hours) to reflect on this wild ride—and we've brought some people you might recognize! In this episode, we pull some clips from the archive to help us look back at our best moments, favorite topics, and silliest slip-ups over the years. We take you through our “Top 5” topics that we loved to talk about the most: electronic health records, patient privacy, public health, health equity, and AI. We will also share some stories you didn't hear (like that time we forgot to hit records—oops), how the pandemic reshaped our personal and professional lives, and the lessons that will stick with us. To lead us through our Top 5, we invited back some of our favorite guests to reflect and discuss the future of the field:  Dr. Yaa Kumah-Crystal, MD, MPH, MS, is an Associate Professor of Biomedical Informatics and Pediatric Endocrinology at Vanderbilt University Medical Center whose research focuses on documentation in healthcare communication. Dr. Ellen Wright Clayton, JD, MD, is a professor of Pediatrics, Law, and Health Policy at Vanderbilt University Law School and Vanderbilt University Medical Center. Her research focuses on the ethical, legal, and social implications of genomics research. Dr. Melissa McPheeters, PhD, MPH, is the Senior Director for Analytics at RTI International, as well as an esteemed epidemiologist and public health informatician. Her work focuses on building interdisciplinary teams to address complex problems across health, public health, and data modernization processes. Dr. Consuelo H. Wilkins, MD, is the Senior Vice President and Senior Associate Dean of Health Equity at Vanderbilt University Medical Center and the Associate Director of the Vanderbilt Institute for Clinical and Translational Research. Her work attempts to bring together community stakeholders and create collaboration initiatives to improve community health and biomedical research. Dr. Chris Callison-Burch, PhD, MS, is a Professor of Computer and Information Science at the University of Pennsylvania. His research focuses on natural language processing and generative AI. So, is this really goodbye? Maybe, maybe not. We can never sit still for long. But for now, let's raise a glass, share a few laughs, and remember the good ol' times! We can't leave without saying thank you to all of you for being part of the ride, for listening to us on your jog or your commute, and for engaging critically with all we've had to say. It's been an honor. Thank you to all the guests who have joined us throughout the last five years. Thank you for contributing your expertise, your lived experiences, and your unfiltered thoughts. Thank you to the musicians who bravely stepped into conversations about topics they knew little about and for offering up their questions. You ensured we spoke to everyone, and your music said the rest of what our words couldn't convey. To all our guests, your generosity with your time and your knowledge is what made this podcast what it was. Our mission was always to make informatics intelligible so that you and all your friends and family can engage confidently with the topic. We hope you now have the language to feel empowered navigating this crazy, awesome, flawed, fascinating healthcare system.  For now, this is Kevin Johnson, Harris Bland, and Ellie Shuert signing off! Mentioned in the episode: -Hidden Brain podcast -Scott Scovill and Moo TV, plus his appearance on episode 4: “Automated Resilience: Biomedical Informatics as a Safety Net for Life” -Nancy Lorenzi in “Informatics and Anti-Black Racism: What We Need to Do” (Jun. 2020) -Trent Rosenbloom in “21st Century Cures: Curing our Anxiety or Causing It?” (May 2021) -Hey Epic! -Brad Malin in “Data Privacy: Possible, Impossible, or Somewhere In Between?” (Aug. 2020) -Moore v. Regents of the University of California (1990) -”Learning Health Care and the Obligation to Participate in Research” by Ruth R. Faden and Nancy E. Kass (Hastings Center Report) -”The Right to Privacy” by Samuel D. Warren II and Louis Brandeis (Harvard Law Review) -Revenge of the Tipping Point: Overstories, Superspreaders, and the Rise of Social Engineering by Malcolm Gladwell -Colin Walsh in “COVID and the Hidden Data Gap” (Feb. 2021) -Bryant Thomas Karras in “Get Your Dose of Data! An Introduction to Public Health Informatics” (Jul. 2024) STE and public health highway? -Consuelo Wilkins in “Clinical Trials: Are We Whitewashing the Data?” (Nov. 2023) -Where Do We Go from Here: Chaos or Community? by Martin Luther King Jr. -Michael Matheny and Tom Lasko in “AI and Medicine: The Slippery Slope to an Uncertain Future” (Feb. 2020) -Lyle Ungar and Angela Bradbury in “Chatbots in Healthcare: The Ultimate Turing Test” (Aug. 2024) -“A Textbook Remedy for Domain Shifts: Knowledge Priors for Medical Image Analysis” by Yue Yang, Mona Gandhi, Yufei Wang, Yifan Wu, Michael S. Yao, Chris Callison-Burch, James C. Gee, Mark Yatskar (NeurIPS) -Google DeepMind -OpenAI's Deep Research -The Thinking Game (2024) dir. by Greg Kohs -“Dolly the Sheep: A Cautionary Tale” by Robin Feldman and Vern Norviel (Yale Journal of Law & Technology) -Who, Me? Children's book series -The Influencers Substack Follow our social media platforms to stay up to date on our new projects!

Why are we increasingly putting greedy corporations in charge of what life-saving health care our elderly are allowed to have? Plus - new evidence that people in Republican majority regions are more likely to die young just because they can't afford to see a doctor.Plus - Thom reads from 'Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices' by Robin Feldman.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With new Covid strains circulating, why is the G.O.P. working against Biden's efforts to make prescription drugs affordable? And then-- is there a link between sugary beverages and depression?Plus Thom reads from 'Drugs, Money, and Secret Handshakes' by Robin Feldman.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

I talk with Dr. Kevin Conners about natural, supplementary, and alternative options for cancer. Chapters: 00:00:00 Dr. Kevin Conners https://www.connersclinic.com/ 00:03:10 Rife and Electromedicine https://amzn.to/3pZwpcM 00:04:25 Frequencies and electromedicine 00:08:25 Immune system and cancer 00:10:25 The Truth About Cancer https://amzn.to/37s8yfB 00:13:30 Frequencies for different types of cancers 00:16:25 Quality of life 00:17:00 Success rate of traditional medicine 00:18:00 Hoxsey Therapy https://amzn.to/3tP2fdC 00:18:15 Side effects of chemotherapy 00:19:45 Pharmacratic state against alternatives https://youtu.be/JuLsL3_eBWw 00:25:10 Robin Feldman https://amzn.to/3pVvpXh 00:25:15 Per Bylund https://youtu.be/sWe3Bv5Durc 00:26:10 Can the body fight off cancer? 00:27:10 Conners Clinic 00:28:45 Testing 00:29:10 Self-care 00:30:40 Success of alternatives 00:32:35 Goal is to stop replication 00:35:45 Combined care 00:37:00 Cancer prevention 00:37:10 Avoid toxins 00:38:30 Detoxification 00:39:00 Plastics 00:40:00 Soy 00:40:20 Hormone driven cancer 00:41:20 Fasting 00:48:40 Ketogenic diet 00:50:50 Supplements 00:54:28 Things to avoid when you have cancer 00:56:45 Chemotherapy 00:59:40 Fasting and chemotherapy 01:03:00 Stay calm do your own research 01:04:00 Spontaneous remission and background rates --- Send in a voice message: https://anchor.fm/aaronolson/message Support this podcast: https://anchor.fm/aaronolson/support

I talk with Dr. Kevin Conners about natural, supplementary, and alternative options for cancer. Chapters: 00:00:00 Dr. Kevin Conners https://www.connersclinic.com/ 00:03:10 Rife and Electromedicine https://amzn.to/3pZwpcM 00:04:25 Frequencies and electromedicine 00:08:25 Immune system and cancer 00:10:25 The Truth About Cancer https://amzn.to/37s8yfB 00:13:30 Frequencies for different types of cancers 00:16:25 Quality of life 00:17:00 Success rate of traditional medicine 00:18:00 Hoxsey Therapy https://amzn.to/3tP2fdC 00:18:15 Side effects of chemotherapy 00:19:45 Pharmacratic state against alternatives https://youtu.be/JuLsL3_eBWw 00:25:10 Robin Feldman https://amzn.to/3pVvpXh 00:25:15 Per Bylund https://youtu.be/sWe3Bv5Durc 00:26:10 Can the body fight off cancer? 00:27:10 Conners Clinic 00:28:45 Testing 00:29:10 Self-care 00:30:40 Success of alternatives 00:32:35 Goal is to stop replication 00:35:45 Combined care 00:37:00 Cancer prevention 00:37:10 Avoid toxins 00:38:30 Detoxification 00:39:00 Plastics 00:40:00 Soy 00:40:20 Hormone driven cancer 00:41:20 Fasting 00:48:40 Ketogenic diet 00:50:50 Supplements 00:54:28 Things to avoid when you have cancer 00:56:45 Chemotherapy 00:59:40 Fasting and chemotherapy 01:03:00 Stay calm do your own research 01:04:00 Spontaneous remission and background rates --- Send in a voice message: https://anchor.fm/aaronolson/message Support this podcast: https://anchor.fm/aaronolson/support

Americans pay more for prescription drugs than people in other countries do. As medicines become increasingly unaffordable — particularly for people with low incomes — policymakers in both parties are feeling the urgency to address the problem. But what could they do? On the latest episode of The Dose podcast, Robin Feldman, a professor at the UC Hastings College of Law and an expert on intellectual property and pharmaceutical law, offers some answers. She talks about the problems with our current patent system, and how it could be redesigned to allow for innovation and to protect consumers from going into debt to pay for their medications.

Mark Luschini, chief investment strategist for Janney Montgomery Scott, says that the stock market is likely to follow the growth of corporate profits, which bodes well for heady gains over the next year or two, despite inflation and other concerns that will increase volatility and potentially cause setbacks. Luschini says that since grizzly and protracted bear markets rarely occur outside of a recession -- and with recession seeming like a remote possibility in the next 12 to 24 months -- investors should be prepared to stay the course but ride out the bumps. Also on the show, John Smallwood of Smallwood Wealth Management talks about factoring inflationary pressure into long-term portfolio decisions, law professor Robin Feldman discusses how the U.S. patent system currently is incentivizing failure and causing higher prices in health care, and David Trainer of New Constructs talks about how operating earnings measures are actually distorting the financial picture of companies like Marathon Petroleum and eBay.

Uncertainty Over Cost and Access to Future COVID-19 Exposes Flaws in US Drug System (0:30)Guest: Robin Feldman, Arthur J. Goldberg Distinguished Professor of Law, Director of the Center for Innovation at University of California Hastings, Author of "Drugs, Money, & Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices"A vaccine for COVID-19 is currently being tested on humans in Seattle, but it'll be at least a year before it's available publicly. Even then, it's unclear who will be able to afford it. That all depends on how much the drug company that develops the vaccine decides to charge for it and how much of that cost health insurers will cover. You would think that a vaccine like this would be somehow made available to everyone regardless of cost – but that's not how our system works, says Robin Feldman. Emotionally Intelligent Bosses (22:38)Guest: Zorana Ivcevic Pringle, Research Scientist for the Yale Center for Emotional IntelligenceIf you're working from home now, tensions might be high between you, your boss, and other coworkers. Remote working sure makes it easy for miscommunications to happen. But a new study out of Yale University shows that if supervisors recognize and acknowledge high emotions, employees are happier and more creative. And not just when we're all in crisis. Community Theater for Neurodiverse Performers and Audiences (39:26)Guest: Karalyn Joseph, Student at Harvard University, Founder and Director of the Community of Actors Sharing in Theatre (C.A.S.T.).As a high school junior, Karalyn Joseph started a community theater program for people with disabilities. Today, Joseph is a junior at Harvard, studying theater and neuroscience and she continues to direct the C.A.S.T. Theatre group in her Pennsylvania hometown. Apple Seed (50:40)Guest: Sam Payne, Host, The Apple Seed, BYUradioSam Payne waxes nostalgic on one of the best tricks on April Fool's Day. Prosecutors Are Using Rap Lyrics as Evidence in Court (1:03:05)Guest: Erik Nielson, Associate Professor of Liberal Arts, University of RichmondGangsta rap is notoriously violent and vulgar, bragging about killing cops, shooting rivals, assaulting women, and selling drugs. It's perhaps not surprising then, that lyrics like that have been used as evidence in hundreds of court cases charging rappers with crimes.  But that's not what happens to other types of artists – Johnny Cash didn't get charged with murder for singing, “I shot a man in Reno just to watch him die.” Nobody called Francis Ford Coppola a mobster because he made “The Godfather” movies. Erik Nielson says using a rapper's lyrics against them in trial is a violation of Free Speech – and it's also racist. Why the Ultra-Rich Are Putting Their Money Into South Dakota (1:20:36)Guest: Oliver Bullough, Contributor to the Guardian, Author of “Moneyland: Why Thieves and Crooks Now Rule the World and How to Take It Back”Time was, the world's super-rich would park their billions in a place like Panama, Switzerland or the Cayman Islands to avoid paying taxes. Today, they're just as likely to send their money to the United States, and South Dakota is leading the way.

Robin Feldman, Univ of California Hastings, on a COVID-19 vaccine. Zorana Pringle of The Yale Center for Emotional Intelligence on emotional intelligence. Karalyn Joseph, student at Harvard Univ, on neurodiverse theater. Sam Payne from the Apple Seed on April Fool's Day. Erik Nielson, Univ of Richmond, on using rap lyrics in court. Oliver Bullough, author of “Moneyland: Why Thieves and Crooks Now Rule the World and How to Take It Back” on South Dakota trusts.

Trump retweeted a picture of himself playing a violin. Seriously. It's like he's trying to tell us in the most obvious way possible that he doesn't give a damn. America is on fire and our leader is fiddling. What could possibly go wrong?Progressive Congressman Ro Khanna joins Thom to field listener questions on the Trump administration's failure to contend with the Covid-19 virus and the impact on our community. For the book club, Thom reads from "Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices" by Robin Feldman.

Should we get rid of drug patents since the government does most of the drug research anyway?.. Why do we have NASA to thank for LASIC eye surgery?.. Jimmy Carter v. Reagan on Medicare For All... If everybody got healthcare, wouldn't that benefit employers and employees both?.. How Republican policies have led to disposable employees... Do we have a health care system, or a health insurance industry?- and does that mean we have nutty priorities that lead to very high levels of serious, but preventable illnesses among Americans like diabetes? And how are people across our country coping with the holes in medical care?Plus Thom reads from 'Drugs, Money, and Secret Handshakes' by Robin Feldman, and his own book 'Walking Your Blues Away'.

Trump is working as fast and as furiously as he can to destroy Medicare before it can become Medicare for All... Meanwhile, Thom and his callers look at Medigap plans, Medicare "Advantage"... what options are out there, and which are they not telling us about? How could some of these plans figure into a sneaky plan to crash real Medicare?.. and what is health care really like in Canada and England? Plus, Thom reads from the book 'Drugs, Money, and Secret Handshakes' by Robin Feldman, and from his own book 'Walking Your Blues Away'.

In the first segment, Dr. Stacey Clardy talks with Dr. Anastasia Zekeridou about her paper on Phosphodiesterase 10A-IgG, a novel biomarker of paraneoplastic neurological autoimmunity. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Prof. Robin Feldman on “evergreening” and drug prices. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.    Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.

The leading cause of bankruptcy in the U.S. is from medical costs. Big Pharma is front-and-center to this problem. Robin Feldman joins Robert & Kim to discuss her research into how Big Pharma oftentimes secretly works to keep drug prices high and thwart free-market competition. Find out why U.S. citizens subsidize drug prices around the world. Robin offers tips on how you can protect yourself from medical bankruptcy. Learn more about your ad choices. Visit megaphone.fm/adchoices

Recent months have seen a variety of proposals to bring down the cost of prescription drugs, but will any of them have staying power? This week, senior editor Allison Inserro speaks with Robin Feldman, professor at the University of California, Hastings, College of the Law, and author of the new book Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.

Law professor and author Robin Feldman of UC Hastings College of the Law talks about her book Drugs, Money, and Secret Handshakes with EconTalk host Russ Roberts. Feldman argues that the legal and regulatory environment for drug companies encourages those companies to seek drugs that extend their monopoly through the patent system often with insufficient benefit for consumers. The prices for those drugs are then protected from new competition. She also argues that the pharmacy benefit management system allows drug companies to exploit consumers. The conversation concludes with a discussion of what can be done to improve the situation.

Law professor and author Robin Feldman of UC Hastings College of the Law talks about her book Drugs, Money, and Secret Handshakes with EconTalk host Russ Roberts. Feldman argues that the legal and regulatory environment for drug companies encourages those companies to seek drugs that extend their monopoly through the patent system often with insufficient benefit for consumers. The prices for those drugs are then protected from new competition. She also argues that the pharmacy benefit management system allows drug companies to exploit consumers. The conversation concludes with a discussion of what can be done to improve the situation.

College professor and author Robin Feldman said that secret deals and strategies used by the drug industry has medicine costs rising even when they shouldn't be. The system, she explained, favors higher-cost drugs at the expense of more-affordable care. Also on the show, the gang from HighTower Advisors -- Jimmy Hausburg, Jeff Kelly and Ray Baraldi this week -- identify the emerging industries they are most intrigued by now, and Ryan Jacob of the Jacob funds has the Market Call.

Ryan Vogel of UVU talks about the murder of journalist Jamal Khashoggi. Robin Feldman of the UC Hastings College of Law unpacks the prescription drug empire. Amy Moore of Washington University School of Medicine on nerve transfer. Sebastian Purcell of SUNY-Cortland discusses Aztec wisdom. The clan Buchanan by David Byrne of the Clan Buchanan Society International. Amy Bentley of New York University. Amy Bentley of New York University shares why ketchup is the perfect American condiment.

Why Are Prescription Drug Prices So High? Rick tries to answer the question with Robin Feldman, author of the forthcoming book Drugs, Money, & Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices. Plus the Wisconsin GOP power grab. You can call in to the show any time at (833) 711-RICK. That's (833) 711-7425.

Robin Feldman, Univ of California, discusses Purdue Pharma's role in worsening the opioid crisis. Utah Online School's Laura Belnap explains the online public school trend. Jeffery Tessem researches a potential diabetes treatment. David Feldman, College of William and Mary, gives the real reason why college tuition is rising. Thomas Peele of Bay Area News Group describes the investigative journalist process. BYUradio's Rachel Wadham argues that dystopian novels are good for teens.

Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.

Robin Feldman, director of the Institute for Innovation Law at UC Hastings, and Gregory Dolin, co-director of the Center for Medicine and Law at the University of Baltimore, discuss Tuesday's ruling in the Supreme Court case Impression Products v. Lexmark International. They speak June Grasso and Greg Stohr on Bloomberg Radio's "Bloomberg Law." Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Robin Feldman, director of the Institute for Innovation Law at UC Hastings, and Gregory Dolin, co-director of the Center for Medicine and Law at the University of Baltimore, discuss Tuesday's ruling in the Supreme Court case Impression Products v. Lexmark International. They speak June Grasso and Greg Stohr on Bloomberg Radio's "Bloomberg Law."